Abstract
Objective
To present data on the self-reported use of all types of medicinal products collected during pregnancy in a large cohort in southwest England.
Methods
Pregnant women with a delivery date during 1991-1992 and forming part of the prospective, population-based Avon Longitudinal Study of Parents and Children (ALSPAC) were sent up to four self-completion postal questionnaires during pregnancy. Text data collected from the questions on drug usage were coded using an ALSPAC drug dictionary based on the World Health Organization Drug Dictionary.
Results
At least one antenatal self-completion questionnaire was completed for 14,119 pregnancies, and 11,545 women completed all four. The data included prescription, over-the-counter, herbal and homeopathic products as well as iron, vitamins and other supplements. Only 7.6% did not report use of any medicinal product throughout their entire pregnancy. The remaining 92.4% used at least one product at some stage. After exclusion of iron, folate, vitamins, supplements, herbal and homeopathic products and skin emollients, 83% of those completing all questionnaires had used conventional therapeutic drugs. Analgesics were reported by approximately one-third of women at each stage during pregnancy, and paracetamol was the most frequently reported substance. Iron preparations were reported by 33% of the full cohort, at some stage, and folate by 21.9%. Use of anti-anaemic products increased during pregnancy with the greatest incidence at 32 weeks. Other vitamins and supplements were taken by 17.4% at some stage. Use of vitamins decreased throughout pregnancy from 9.6% in early pregnancy to 5% at 32 weeks. Antacids were reported by 23% at 32 weeks. The reported incidence of antibiotic use decreased slightly during pregnancy from 8% early on to 5.8% at 32 weeks; amoxicillin was the most frequently reported antibacterial.
Conclusion
Use of medicinal products was high during pregnancy in the ALSPAC cohort. This finding is consistent with data from recent publications.
Similar content being viewed by others
References
Koren G, Pastuszak A, Shinya I (1998) Drugs in pregnancy. N Engl J Med 338:1128–1137
Rubin P (1998) Drug treatment during pregnancy. BMJ 317:1503–1506
Sørensen HT, Nielsen GL, Andersen A-MN, Zhou WJ, Steffensen FH, Olesen C, Olsen J (1996) Drug use in pregnancy. Principal problems and a review of newer utilization studies. Clin Res Reg Affairs 13:181–197
Aviv RI, Chubb K, Londow SW (1993) The prevalence of maternal medication ingestion in the antenatal period. S Afr Med J 83:657–660
Bonati M, Bortolus R, Marchetti F, Romero M, Tognoni G (1990) Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol 38:325–328
Collaborative group on drug use in pregnancy (C.G.D.U.P.) (1992) Medication during pregnancy: an intercontinental cooperative study. Int J Gynaecol Obstet 39:185–196
Costa da Fonseca MRC, da Fonseca E, Bergsten-Mendes G (2002) Prevalence of drug use during pregnancy: a pharmacoepidemiological approach. Rev Saude Publica 36:205–212
De Vigan C, De Walle HEK, Cordier S, Goujard J, Knill-Jones R, Aymé S, Calzolari E, Bianchi F, and the OECM Working Group (1999) Therapeutic drug use during pregnancy. A comparison in four European countries. J Clin Epidemiol 52:977–982
Donati S, Baglio G, Spinelli A, Grandolfo ME (2000) Drug use in pregnancy among Italian women. Eur J Clin Pharmacol 56:323–328
Glover DD, Amonkur M, Rybeck BF, Tracy TS (2003) Prescription, over-the-counter, and herbal medicine use in a rural, obstetric population. Am J Obstet Gynecol 188:1039–1045
Henry A, Crowther C (2000) Patterns of medication use during and prior to pregnancy: the MAP study. Aust N Z J Obstet Gynaecol 40:154–172
Irl C, Hasford J, PEGASUS Study Group (1997) The PEGASUS project—a prospective cohort study for the investigation of drug use in pregnancy. Int J Clin Pharmacol Ther 35:572–576
Jiménez E, Bosch F, López A, Costa J, Cos R, Baños JE (1998) Patterns of regular drug use in Spanish childbearing women: changes elicited by pregnancy. Eur J Clin Pharmacol 54:645–651
Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Montastruc JL (2000) Prescription of drugs during pregnancy in France. Lancet 356:1735–1736
Oleson C, Steffensen FH, Nielson GL, de Jong-van den Berg L, Olsen J, Sørensen HT, The EuroMAP Group (1999) Drug use in first pregnancy and lactation: a population-based survey among Danish women. Eur J Clin Pharmacol 55:139–144
Rubin JD, Ferencz C, Loffredo C (1993) Use of prescription and non-prescription drugs in pregnancy. The Baltimore-Washington infant study group. J Clin Epidemiol 46:581–589
Golding J, Pembrey M, Jones R, and the ALSPAC Study Team (2001) ALSPAC—The Avon longitudinal study of parents and children I. Study methodology. Paediatr Perinat Epidemiol 15:74–87
Oleson C, Søndergaard C, Thrane N, Lauge Nielson G, de Jong-van den Berg L, Olsen J, for the EuroMAP Group (2001) Do pregnant women report use of dispensed medications? Epidemiology 12:497–501
Harlow SD, Linnet MS (1989) Agreement between questionnaire data and medical records. The evidence for accuracy of recall. Am J Epidemiol 129:233–248
Rockenbauer M, Olsen J, Czeizel AE, Pedersen L, Sørensen HT, and the EuroMAP Group (2001) Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology 12:461–466
De Jong-van den Berg, LT, Waardenburg CM, Haaijer-Ruskamp FM, Dukes MN, Wesseling H (1993) Drug use in pregnancy: a comparative appraisal of data collecting methods. Eur J Clin Pharmacol 45:9–14
Mitchell AA, Cottler LB, Shapiro S (1986) Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol 123:670–676
Rubin PC, Craig GF, Gavin K, Sumner D (1986) Prospective survey of use of therapeutic drugs, alcohol, and cigarettes during pegnancy. BMJ 292:81–83
Forfar JO, Nelson MM (1973) Epidemiology of drugs taken by pregnant women: drugs that may affect the fetus adversely. Clin Pharmacol Ther 14:632–642
Shaheen SO, Newson RB, Sherriff A, Henderson, AJ, Heron JE, Burney PGJ, Golding J (2002) Paracetamol use in pregnancy and wheezing in early childhood. Thorax 57:958–963
Acknowledgements
We are extremely grateful to all the mothers who took part and to the midwives for their co-operation and help in recruitment. The whole ALSPAC study team comprises interviewers, computer technicians, laboratory technicians, clerical workers, research scientists, volunteers and managers who continue to make the study possible. This study could not have been undertaken without the financial support of various organisations including the Wellcome Trust, the Medical Research Council, the University of Bristol, the Department of Health and the Department of the Environment. The ALSPAC study is part of the WHO-initiated European Longitudinal Study of Pregnancy and Childhood. The study complies with current British law including ethics approval.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Headley, J., Northstone, K., Simmons, H. et al. Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children. Eur J Clin Pharmacol 60, 355–361 (2004). https://doi.org/10.1007/s00228-004-0775-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-004-0775-7